The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway
The identification of cancer-associated mutations in the tricarboxylic acid (TCA) cycle enzymes isocitrate dehydrogenases 1 and 2 (IDH1/2) highlights the prevailing notion that aberrant metabolic function can contribute to carcinogenesis. IDH1/2 normally catalyse the oxidative decarboxylation of iso...
Những tác giả chính: | Carbonneau, M, M Gagné, L, Lalonde, M, Germain, M, Motorina, A, Guiot, M, Secco, B, Vincent, E, Tumber, A, Hulea, L, Bergeman, J, Oppermann, U, Jones, R, Laplante, M, Topisirovic, I, Petrecca, K, Huot, M, Mallette, F |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
Springer Nature
2016
|
Những quyển sách tương tự
-
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases.
Bằng: Chowdhury, R, et al.
Được phát hành: (2011) -
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Bằng: Chowdhury, R, et al.
Được phát hành: (2011) -
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Bằng: Chowdhury, R, et al.
Được phát hành: (2011) -
Human Phosphoglycerate Dehydrogenase Produces the Oncometabolite d-2-Hydroxyglutarate
Bằng: Teng, Xin, et al.
Được phát hành: (2016) -
Oncometabolite 2-hydroxyglutarate regulates anti-tumor immunity
Bằng: Mengyuan Cai, et al.
Được phát hành: (2024-01-01)